Sedano, Rosa L.

HRN: 28-74-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2026
CEFUROXIME 750MG (VIAL)
04/04/2026
04/11/2026
IV
750mg
Q8h
S/P ORIF, Left Femur
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: